Inventages

Inventages is a global venture capital firm specializing in life sciences investments, with over $1.5 billion in committed capital. The firm operates from offices in Nassau (Bahamas), Geneva (Switzerland), Auckland (New Zealand), and London (United Kingdom). Its investment focus includes pharmaceuticals, nutraceuticals, medical food, nutrition, cosmeceuticals, innovative food, as well as consumer relation management, processes, and novel packaging technologies. Inventages strives to contribute to the growth of the management teams and companies in which it invests by leveraging its experience, network, and relationships.

The firm's investment strategy encompasses various stages, including seed, early, mid, and late-stage ventures. Inventages has a diverse portfolio across multiple industries, such as healthcare, nutrition, wellness, pharmaceuticals, nutraceuticals, medical food, cosmeceuticals, innovative food, consumer relation management, packaging technologies, supply chain management, biotechnology, genomics, proteomics, and metabolomics.

Inventages has been involved in several notable investments, including a €7 million first close of a Series C financing round for AM-Pharma in 2019. The firm has also invested in companies like Vital Foods in New Zealand and XO in Germany, both of which have ceased operations since 2020 and 2022, respectively. These investments reflect Inventages' commitment to advancing innovative solutions in the life sciences sector.